Arcadia Biosciences, Inc. (RKDA) Form 10-Q Quarterly Reports
Arcadia Biosciences, Inc. (RKDA) is a publicly traded company on the Nasdaq, categorized under SIC 1311 (Crude Petroleum & Natural Gas). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RKDA
CIK: 1469443
Exchange: Nasdaq
SIC 1311: Crude Petroleum & Natural Gas
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerShannon Schroeder
Audit LocationTempe, Arizona, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-09-30 | — | S-8 | 0001193125-26-409063 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-30 | — | SCHEDULE 13G Filing | 0002103370-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-10 | 8-K | 0001193125-26-391780 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390532 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390528 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390521 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390520 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-08-31 | 8-K | 0001193125-26-383642 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003613 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349205 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349180 | View SEC Doc Filr Page |
| ARS | 2026-08-10 | 2025-12-31 | ARS | 0001193125-26-342445 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-10 | 2026-08-10 | DEF 14A | 0001193125-26-342437 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-04 | 8-K | 0001193125-26-340664 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-31 | 2025-12-31 | PRE 14A | 0001193125-26-328642 | View SEC Doc Filr Page |
| 424B3 | 2026-07-09 | — | 424B3 | 0001193125-26-298841 | View SEC Doc Filr Page |
| EFFECT | 2026-07-08 | — | EFFECT Filing | 9999999995-26-002229 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-01 | 8-K | 0001193125-26-294619 | View SEC Doc Filr Page |
| D | 2026-06-26 | — | D Filing | 0001469443-26-000002 | View SEC Doc Filr Page |
| S-3 | 2026-06-26 | — | S-3 | 0001193125-26-285578 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-11 | 8-K | 0001193125-26-270560 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001172661-26-002169 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-223990 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-223985 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001193125-26-197315 | View SEC Doc Filr Page |